Groth M, Malicka J, Czaplewski C, Ołdziej S, Lankiewicz L, Wiczk W, Liwo A
Faculty of Chemistry, University of Gdańsk, Poland.
J Biomol NMR. 1999 Dec;15(4):315-30. doi: 10.1023/a:1008349424452.
A method is proposed to determine the conformational equilibrium of flexible polypeptides in solution, using the data provided by NMR spectroscopy and theoretical conformational calculations. The algorithm consists of the following three steps: (i) search of the conformational space in order to find conformations with reasonably low energy; (ii) simulation of the NOE spectrum and vicinal coupling constants for each of the low energy conformations; and (iii) determining the statistical weights of the conformations, by means of the maximum-entropy method, in order to obtain the best fit of the averaged NOE intensities and coupling constants to the experimental quantities. The method has been applied to two cyclic enkephalin analogs: DNS1-c-[D-A2bu2,Trp4,Leu5]enkephalin (ENKL) and DNS1-c-[D-A2bu2,Trp4,D-Leu5]enkephalin (ENKD). NMR measurements were carried out in deuterated dimethyl sulfoxide. Two techniques were used in conformational search: the electrostatically driven Monte Carlo method (EDMC), which results in extensive search of the conformational space, but gives only energy minima, and the molecular dynamics method (MD), which results in a more accurate, but also more confined search. In the case of EDMC calculations, conformational energy was evaluated using the ECEPP/3 force field augmented with the SRFOPT solvation-shell model, while in the case of MD the AMBER force field was used with explicit solvent molecules. Both searches and subsequent fitting of conformational weights to NMR data resulted in similar conformations of the cyclic part of the peptides studied. For both ENKL and ENKD a common feature of the low-energy solution conformations is the presence of a type II' or type IV beta-turn at residues 3 and 4; the ECEPP/3 force field also gives a remarkable content of type III beta-turn. These beta-turns are tighter in the case of ENKL, which is reflected in different distributions of the D-A2bu(N gamma H)...D-A2bu(CO) and D-A2bu(N gamma H)...Gly3(CO) hydrogen-bonding distances, indicating that the D-A2bu(N gamma H) amide proton is more shielded from the solvent than in the case of ENKD. This finding conforms with the results of temperature coefficient data of the D-A2bu(N gamma H) proton. It has also been found that direct (MD) or Boltzmann (EDMC) averages of the observables do not exactly conform with the measured values, even when explicit solvent molecules are included. This suggests that improving force-field parameters might be necessary in order to obtain reliable conformational ensembles in computer simulations, without the aid of experimental data.
本文提出了一种利用核磁共振光谱提供的数据和理论构象计算来确定溶液中柔性多肽构象平衡的方法。该算法由以下三个步骤组成:(i)搜索构象空间以找到能量合理较低的构象;(ii)模拟每个低能量构象的核Overhauser效应(NOE)光谱和邻位耦合常数;(iii)通过最大熵方法确定构象的统计权重,以便使平均NOE强度和耦合常数与实验值达到最佳拟合。该方法已应用于两种环脑啡肽类似物:DNS1-c-[D-A2bu2,Trp4,Leu5]脑啡肽(ENKL)和DNS1-c-[D-A2bu2,Trp4,D-Leu5]脑啡肽(ENKD)。核磁共振测量在氘代二甲基亚砜中进行。在构象搜索中使用了两种技术:静电驱动蒙特卡罗方法(EDMC),它能广泛搜索构象空间,但只给出能量最小值;分子动力学方法(MD),它能进行更精确但范围也更有限的搜索。在EDMC计算中,使用ECEPP/3力场并结合SRFOPT溶剂化壳模型来评估构象能量,而在MD计算中,使用AMBER力场并包含明确的溶剂分子。对构象权重进行搜索并随后拟合到核磁共振数据,得到了所研究肽环部分相似的构象。对于ENKL和ENKD,低能量溶液构象的一个共同特征是在残基3和4处存在II'型或IV型β-转角;ECEPP/3力场也给出了相当数量的III型β-转角。在ENKL中这些β-转角更紧密,这反映在D-A2bu(NγH)...D-A2bu(CO)和D-A2bu(NγH)...Gly3(CO)氢键距离的不同分布上,表明D-A2bu(NγH)酰胺质子比在ENKD中更受溶剂屏蔽。这一发现与D-A2bu(NγH)质子的温度系数数据结果相符。还发现,即使包含明确的溶剂分子,可观测量的直接(MD)或玻尔兹曼(EDMC)平均值也不完全与测量值相符。这表明在不借助实验数据的计算机模拟中,可能需要改进力场参数以获得可靠的构象集合。